The Ki67 labeling index is recognized as a significant indicator of tumor cell proliferation in cases of GBM, with high Ki67 levels being linked to poorer overall survival in patients with lower grade gliomas or ependymomas [57, 58]. Here, MKI67 is linked to glioblastoma.